The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picks3i Group Regulatory News (III)

Share Price Information for 3i Group (III)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2,891.00
Bid: 2,879.00
Ask: 2,881.00
Change: 49.00 (1.72%)
Spread: 2.00 (0.069%)
Open: 2,853.00
High: 2,891.00
Low: 2,846.00
Prev. Close: 2,842.00
III Live PriceLast checked at -
3i Group is an Investment Trust

To provide its shareholders with quoted access to private equity and infrastructure returns, its main focus is on making quoted and unquoted equity and/ or debt investments in businesses and funds in Europe, Asia and the Americas.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Update on Action valuation

30 Jun 2016 07:00

RNS Number : 7191C
3i Group PLC
30 June 2016
 

30 June 2016

 

 

3i Group plc

Update on Action valuation

Since the publication of 3i Group plc's ("3i" or "the Group") financial results for the year to 31 March 2016, 3i has received a number of approaches in respect of Action, the Group's largest portfolio investment.

 

Action continues to grow strongly and, based on trading to mid-June, is performing on a trajectory similar to its 2015 performance with a similar level of like-for-like sales growth. Action is currently also on track to open materially more new stores this year than it did last year.

 

In light of the third-party interest in Action and its continuing growth and financial trajectory, the Board of 3i has decided to increase the book value of its investment in Action to £1,464 million1 after liquidity discount as at 30 June 2016 (31 March 2016: £902 million). This implies a post discount run-rate EBITDA multiple of 18.2x applied to the run-rate earnings as at 31 March 20162. The book valuation of £1,464 million amounts to a less than 15x projected run-rate EBITDA as at 31 December 20162 on the assumption that Action continues to grow on its current trajectory for the remainder of this calendar year.

 

3i is actively engaged in the further development of Action and is not intending to sell its investment or organise a flotation of Action in the near future.

 

We will publish our Q1 performance update on 27 July 2016, which will include this adjustment and the results of our quarterly portfolio valuation.

 

Notes

1. Action's valuation currency is euros. The GBP equivalents at 30 June 2016 in this update have been calculated at a currency exchange rate of €1.2168:£1.

 

2. Action is valued using a multiple of its run-rate earnings for the 12 months to the quarter end preceding the reporting period. The valuation uplift to £1,464 million at 30 June 2016 is calculated using run-rate earnings to 31 March 2016. The valuation as at 31 March 2017 will be calculated using run-rate earnings to 31 December 2016.

 

- Ends -

 

For further information, please contact:

 

Silvia SantoroInvestor Relations DirectorTel: 020 7975 3258

 

Toby Bates

Interim Communications DirectorTel: 020 7975 3032

 

 

About 3i Group

 

3i is a leading international investment manager focused on mid-market Private Equity, Infrastructure and Debt Management. Our core investment markets are northern Europe and North America. For further information, please visit: www.3i.com.

 

The financial information in this update is unaudited and is presented on 3i's non-GAAP Investment basis in order to provide users with the most appropriate description of the drivers of 3i's performance. Although this update has been prepared based on reasonable assumptions, any statements about the future outlook of 3i or its investments may be influenced by factors that could cause actual outcomes and results to be materially different.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCPGUGPQUPQGRB
Date   Source Headline
18th Jun 20209:00 amRNSDirector/PDMR Shareholding
11th Jun 202010:39 amRNSBlock listing Interim Review
10th Jun 20202:52 pmRNSDirector/PDMR Shareholding
3rd Jun 20201:30 pmRNSDirector/PDMR Shareholding
3rd Jun 202012:00 pmRNSPublication of a Prospectus
29th May 20204:03 pmRNSTotal Voting Rights
29th May 20204:02 pmRNSDirector/PDMR Shareholding
29th May 202010:37 amRNSDTR 6.3.5
27th May 202011:04 amRNSDoc re. 2020 Notice of AGM
20th May 202010:55 amRNSDoc re. 2020 Annual Report and Accounts
14th May 20207:00 amRNSResults for the year to 31 March 2020
30th Apr 20203:09 pmRNSTotal Voting Rights
30th Apr 20203:08 pmRNSDirector/PDMR Shareholding
1st Apr 202010:02 amRNSDirector/PDMR Shareholding
30th Mar 20209:39 amRNSDirector/PDMR Shareholding
30th Mar 20209:38 amRNSDirector/PDMR Shareholding
19th Mar 20208:30 amRNSCovid-19 update and Action Seminar
10th Mar 20202:28 pmRNSHolding(s) in Company
28th Feb 20204:10 pmRNSTotal Voting Rights
28th Feb 20204:07 pmRNSDirector/PDMR Shareholding
20th Feb 202011:30 amRNSHolding(s) in Company
4th Feb 20203:56 pmRNSHolding(s) in Company
31st Jan 20204:18 pmRNSTotal Voting Rights
31st Jan 20204:15 pmRNSDirector/PDMR Shareholding
30th Jan 20207:00 amRNSFY2020 Q3 Performance update
7th Jan 202011:51 amRNSPortfolio Update
3rd Jan 20203:18 pmRNSTotal Voting Rights
3rd Jan 20203:15 pmRNSDirector/PDMR Shareholding
2nd Jan 202011:47 amRNSDirectorate Change
17th Dec 20194:02 pmRNSDirector/PDMR Shareholding
11th Dec 201910:48 amRNSBlock listing Interim Review
3rd Dec 201912:00 pmRNSDirector/PDMR Shareholding
29th Nov 20193:17 pmRNSTotal Voting Rights
29th Nov 20193:13 pmRNSDirector/PDMR Shareholding
14th Nov 20191:39 pmRNSDoc re. Half Yearly Report 2019
14th Nov 20197:00 amRNSHalf-year Report
31st Oct 20192:52 pmRNSTotal Voting Rights
31st Oct 20192:51 pmRNSDirector/PDMR Shareholding
1st Oct 20193:44 pmRNSPortfolio Update
30th Sep 20193:01 pmRNSTotal Voting Rights
30th Sep 20192:52 pmRNSDirector/PDMR Shareholding
23rd Sep 201911:55 amRNSDirector/PDMR Shareholding
18th Sep 20199:00 amRNSPrivate Equity Capital Markets Seminar
2nd Sep 201912:12 pmRNSDirector Declaration
30th Aug 20193:37 pmRNSTotal Voting Rights
30th Aug 20193:36 pmRNSDirector/PDMR Shareholding
21st Aug 20194:22 pmRNSHolding(s) in Company
21st Aug 20199:09 amRNSAdditional Listing
2nd Aug 201910:36 amRNSDirector/PDMR Shareholding
1st Aug 20193:53 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.